Bayer highlights success of prostate cancer drug Nubeqa

Name: Bayer highlights success of prostate cancer drug Nubeqa
Uploaded: 2025-12-03T21:07:26Z
Duration: 57 s
Description: Bayer CEO Bill Anderson discusses the company's pharmaceutical achievements, focusing on Nubeqa, a leading prostate cancer drug. He expresses satisfaction with additional studies demonstrating Nubeqa's benefits across different disease stages and therapy combinations, establishing it as a preferred treatment option for newly diagnosed patients.

The Claman Countdown · FBN · Dec 3, 2025 · 57s

Sign Up Now

Already a subscriber?

Bayer CEO Bill Anderson discusses the company's pharmaceutical achievements, focusing on Nubeqa, a leading prostate cancer drug. He expresses satisfaction with additional studies demonstrating Nubeqa's benefits across different disease stages and therapy combinations, establishing it as a preferred treatment option for newly diagnosed patients.